Managing adults with congenital heart disease in the catheterization laboratory: state of the art

References

• Warnes CA, Williams RG, Bashore TM et al. ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease). Developed in collaboration with the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J. Am. Coll. Cardiol.52(23), e1–e121 (2008).
   PubMedGoogle Scholar
• Rosamond W, Flegal K, Friday G et al. Heart disease and stroke statistics – 2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation115(5), e69–e171 (2007).
   PubMed Web of Science ®Google Scholar
• Chessa M, Carrozza M, Butera G et al. The impact of interventional cardiology for the management of adults with congenital heart defects. Catheter. Cardiovasc. Interv.67(2), 258–264 (2006).
   PubMedGoogle Scholar
• Baumgartner H, Bonhoeffer P, De Groot NM et al. ESC Guidelines for the management of grown-up congenital heart disease (new version 2010): the Task Force on the Management of Grown-up Congenital Heart Disease of the European Society of Cardiology (ESC). Eur. Heart J. DOI: 10.1093/eurheartjk/ehq249 (2010) (Epub ahead of print).
   Google Scholar
• Hoffman JI, Kaplan S. The incidence of congenital heart disease. J. Am. Coll. Cardiol.39(12), 1890–1900 (2002).
   PubMed Web of Science ®Google Scholar
• Hagen PT, Scholz DG, Edwards WD. Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clin. Proc.59(1), 17–20 (1984).
   PubMed Web of Science ®Google Scholar
• Brochu MC, Baril JF, Dore A, Juneau M, De Guise P, Mercier LA. Improvement in exercise capacity in asymptomatic and mildly symptomatic adults after atrial septal defect percutaneous closure. Circulation106(14), 1821–1826 (2002).
   PubMedGoogle Scholar
• Salehian O, Horlick E, Schwerzmann M et al. Improvements in cardiac form and function after transcatheter closure of secundum atrial septal defects. J. Am. Coll. Cardiol.45(4), 499–504 (2005).
   PubMedGoogle Scholar
• Veldtman GR, Razack V, Siu S et al. Right ventricular form and function after percutaneous atrial septal defect device closure. J. Am. Coll. Cardiol.37(8), 2108–2113 (2001).
   PubMed Web of Science ®Google Scholar
• Butera G, Romagnoli E, Saliba Z, Chessa M et al. Percutaneous closure of multiple defects of the atrial septum: procedural results and long-term follow-up. Catheter. Cardiovasc. Interv.76(1), 121–128 (2010).
   PubMedGoogle Scholar
• Bruch L, Winkelmann A, Sonntag S et al. Fenestrated occluders for treatment of ASD in elderly patients with pulmonary hypertension and/or right heart failure. J. Interv. Cardiol.21(1), 44–49 (2008).
   PubMedGoogle Scholar
• Landzberg MJ. Closure of atrial septal defects in adult patients: justification of the ‘tipping point’. J. Interv. Cardiol.14(2), 267–269 (2001).
   PubMedGoogle Scholar
• Stolt VS, Chessa M, Aubry P et al. Closure of ostium secundum atrial septum defect with the Atriasept occluder: early European experience. Catheter. Cardiovasc. Interv.75(7), 1091–1095 (2010).
   PubMed Web of Science ®Google Scholar
• Kim MS, Klein AJ, Carroll JD. Transcatheter closure of intracardiac defects in adults. J. Interv. Cardiol.20(6), 524–545 (2007).
   PubMedGoogle Scholar
• Amin Z, Hijazi ZM, Bass JL, Cheatham JP, Hellenbrand WE, Kleinman CS. Erosion of Amplatzer septal occluder device after closure of secundum atrial septal defects: review of registry of complications and recommendations to minimize future risk. Catheter. Cardiovasc. Interv.63(4), 496–502 (2004).
   PubMed Web of Science ®Google Scholar
• Butera G, Carminati M, Chessa M et al. Percutaneous versus surgical closure of secundum atrial septal defect: comparison of early results and complications. Am. Heart J.151(1), 228–234 (2006).
   PubMed Web of Science ®Google Scholar
• Krumsdorf U, Ostermayer S, Billinger K et al. Incidence and clinical course of thrombus formation on atrial septal defect and patient foramen ovale closure devices in 1,000 consecutive patients. J. Am. Coll. Cardiol.43(2), 302–309 (2004).
   PubMed Web of Science ®Google Scholar
• Chessa M, Butera G, Carminati M. Risk of thrombus formation on devices used to close transcatheter atrial septal defect and patent foramen ovale. J. Am. Coll. Cardiol.44(8), 1712; author reply 1714–1716 (2004).
   PubMedGoogle Scholar
• Murphy JG, Gersh BJ, McGoon MD et al. Long-term outcome after surgical repair of isolated atrial septal defect. Follow-up at 27 to 32 years. N. Engl. J. Med.323(24), 1645–1650 (1990).
   PubMed Web of Science ®Google Scholar
• Roos-Hesselink JW, Meijboom FJ, Spitaels SE et al. Excellent survival and low incidence of arrhythmias, stroke and heart failure long-term after surgical ASD closure at young age. A prospective follow-up study of 21–33 years. Eur. Heart J.24(2), 190–197 (2003).
   PubMed Web of Science ®Google Scholar
• Du ZD, Hijazi ZM, Kleinman CS, Silverman NH, Larntz K. Comparison between transcatheter and surgical closure of secundum atrial septal defect in children and adults: results of a multicenter nonrandomized trial. J. Am. Coll. Cardiol.39(11), 1836–1844 (2002).
   PubMed Web of Science ®Google Scholar
• Khairy P, O’Donnell CP, Landzberg MJ. Transcatheter closure versus medical therapy of patent foramen ovale and presumed paradoxical thromboemboli: a systematic review. Ann. Intern. Med.139(9), 753–760 (2003).
   PubMed Web of Science ®Google Scholar
• Wilmshurst PT, Nightingale S, Walsh KP, Morrison WL. Effect on migraine of closure of cardiac right-to-left shunts to prevent recurrence of decompression illness or stroke or for haemodynamic reasons. Lancet356(9242), 1648–1651 (2000).
   PubMed Web of Science ®Google Scholar
• Schwerzmann M, Wiher S, Nedeltchev K et al. Percutaneous closure of patent foramen ovale reduces the frequency of migraine attacks. Neurology62(8), 1399–1401 (2004).
   PubMed Web of Science ®Google Scholar
• Dowson A, Mullen MJ, Peatfield R et al. Migraine Intervention With STARFlex Technology (MIST) trial: a prospective, multicenter, double-blind, sham-controlled trial to evaluate the effectiveness of patent foramen ovale closure with STARFlex septal repair implant to resolve refractory migraine headache. Circulation117(11), 1397–1404 (2008).
   PubMed Web of Science ®Google Scholar
• Garg P, Servoss SJ, Wu JC et al. Lack of association between migraine headache and patent foramen ovale: results of a case–control study. Circulation121(12), 1406–1412 (2010).
   PubMedGoogle Scholar
• Chessa M, Colombo C, Butera G et al. Is it too early to recommend patent foramen ovale closure for all patients who suffer from migraine? A single-centre study. J. Cardiovasc. Med. (Hagerstown)10(5), 401–405 (2009).
   PubMed Web of Science ®Google Scholar
• Dua JS, Carminati M, Lucente M et al. Transcatheter closure of postsurgical residual ventricular septal defects: early and mid-term results. Catheter. Cardiovasc. Interv.75(2), 246–255 (2010).
   PubMedGoogle Scholar
• Chessa M, Butera G, Negura D et al. Transcatheter closure of congenital ventricular septal defects in adult: mid-term results and complications. Int. J. Cardiol.133(1), 70–73 (2009).
   PubMedGoogle Scholar
• Chessa M, Dua JS, Carminati M. Transcatheter closure of congenital ventricular septal defects in adults mid-term results and complications: few more considerations. Int. J. Cardiol. DOI: 10.1016/j.icard.2009.05.043 (2009) (Epub ahead of print).
   Google Scholar
• Knauth AL, Lock JE, Perry SB et al. Transcatheter device closure of congenital and postoperative residual ventricular septal defects. Circulation110(5), 501–507 (2004).
   PubMed Web of Science ®Google Scholar
• Holzer R, Balzer D, Cao QL, Lock K, Hijazi ZM. Device closure of muscular ventricular septal defects using the Amplatzer muscular ventricular septal defect occluder: immediate and mid-term results of a U.S. registry. J. Am. Coll. Cardiol.43(7), 1257–1263 (2004).
   PubMed Web of Science ®Google Scholar
• Carminati M, Butera G, Chessa M et al. Transcatheter closure of congenital ventricular septal defects: results of the European Registry. Eur. Heart J.28(19), 2361–2368 (2007).
   PubMed Web of Science ®Google Scholar
• Kidd L, Driscoll DJ, Gersony WM et al. Second natural history study of congenital heart defects. Results of treatment of patients with ventricular septal defects. Circulation87(2 Suppl.), I38–I51 (1993).
   Web of Science ®Google Scholar
• Pedra CA, Pedra SR, Chaccur P et al. Periventricular device closure of congenital muscular ventricular septal defects. Expert Rev. Cardiovasc. Ther.8(5), 663–674 (2010).
   PubMedGoogle Scholar
• Aggarwal SK, Barik R. Infective endocarditis of a patent arterial duct in an adult, with vegetations extending to the aortic and pulmonary valves. Cardiol. Young17(5), 565–566 (2007).
   PubMedGoogle Scholar
• Campbell M. Natural history of persistent ductus arteriosus. Br. Heart J.30(1), 4–13 (1968).
   PubMedGoogle Scholar
• Cagli K, Basar FN, Cagli K et al. Multisite infective endocarditis/endarteritis in a young peripartum patient with patent ductus arteriosus and rheumatic heart valve disease: a case report. Echocardiography27(4), 466–469 (2010).
   PubMed Web of Science ®Google Scholar
• Pass RH, Hijazi Z, Hsu DT, Lewis V, Hellenbrand WE. Multicenter USA Amplatzer patent ductus arteriosus occlusion device trial: initial and one-year results. J. Am. Coll. Cardiol.44(3), 513–519 (2004).
   PubMed Web of Science ®Google Scholar
• Lloyd TR, Fedderly R, Mendelsohn AM, Sandhu SK, Beekman RH 3rd. Transcatheter occlusion of patent ductus arteriosus with Gianturco coils. Circulation88(4 Pt 1), 1412–1420 (1993).
   PubMedGoogle Scholar
• Dua J, Chessa M, Piazza L et al. Initial experience with the new Amplatzer Duct Occluder II. J. Invasive Cardiol.21(8), 401–405 (2009).
   PubMedGoogle Scholar
• Rosenfeld HM, Landzberg MJ, Perry SB, Colan SD, Keane JF, Lock JE. Balloon aortic valvuloplasty in the young adult with congenital aortic stenosis. Am. J. Cardiol.73(15), 1112–1117 (1994).
   PubMed Web of Science ®Google Scholar
• von Kodolitsch Y, Aydin MA, Koschyk DH et al. Predictors of aneurysmal formation after surgical correction of aortic coarctation. J. Am. Coll. Cardiol.39(4), 617–624 (2002).
   PubMed Web of Science ®Google Scholar
• Kron IL, Flanagan TL, Rheuban KS et al. Incidence and risk of reintervention after coarctation repair. Ann. Thorac. Surg.49(6), 920–925; discussion 925–926 (1990).
   PubMedGoogle Scholar
• Campbell M. Natural history of coarctation of the aorta. Br. Heart J.32(5), 633–640 (1970).
   PubMedGoogle Scholar
• Knyshov GV, Sitar LL, Glagola MD, Atamanyuk MY. Aortic aneurysms at the site of the repair of coarctation of the aorta: a review of 48 patients. Ann. Thorac. Surg.61(3), 935–939 (1996).
   PubMed Web of Science ®Google Scholar
• Suarez de Lezo J, Pan M, Romero M et al. Balloon-expandable stent repair of severe coarctation of aorta. Am. Heart J.129(5), 1002–1008 (1995).
   PubMed Web of Science ®Google Scholar
• Harrison DA, McLaughlin PR, Lazzam C, Connelly M, Benson LN. Endovascular stents in the management of coarctation of the aorta in the adolescent and adult: one year follow up. Heart85(5), 561–566 (2001).
   PubMed Web of Science ®Google Scholar
• Butera G, Heles M, MacDonald ST, Carminati M. Aortic coarctation complicated by wall aneurysm: The role of covered stents. Catheter. Cardiovasc. Interv. DOI: 10.1002/ccd.22756 (2010) (Epub ahead of print).
   Google Scholar
• Butera G, Gaio G, Carminati M. Redilation of e-PTFE covered CP stents. Catheter. Cardiovasc. Interv.72(2), 273–277 (2008).
   PubMed Web of Science ®Google Scholar
• Hayes CJ, Gersony WM, Driscoll DJ et al. Second natural history study of congenital heart defects. Results of treatment of patients with pulmonary valvar stenosis. Circulation87(2 Suppl.), I28–I37 (1993).
   Google Scholar
• Earing MG, Connolly HM, Dearani JA, Ammash NM, Grogan M, Warnes CA. Long-term follow-up of patients after surgical treatment for isolated pulmonary valve stenosis. Mayo Clin. Proc.80(7), 871–876 (2005).
   PubMedGoogle Scholar
• McCrindle BW, Kan JS. Long-term results after balloon pulmonary valvuloplasty. Circulation83(6), 1915–1922 (1991).
   PubMedGoogle Scholar
• Rao PS, Thapar MK, Kutayli F. Causes of restenosis after balloon valvuloplasty for valvular pulmonary stenosis. Am. J. Cardiol.62(13), 979–982 (1988).
   PubMedGoogle Scholar
• Peng LF, McElhinney DB, Nugent AW et al. Endovascular stenting of obstructed right ventricle-to-pulmonary artery conduits: a 15-year experience. Circulation113(22), 2598–2605 (2006).
   PubMed Web of Science ®Google Scholar
• Bonhoeffer P, Boudjemline Y, Saliba Z et al. Percutaneous replacement of pulmonary valve in a right-ventricle to pulmonary-artery prosthetic conduit with valve dysfunction. Lancet356(9239), 1403–1405 (2000).
   PubMed Web of Science ®Google Scholar
• Coats L, Khambadkone S, Derrick G et al. Physiological and clinical consequences of relief of right ventricular outflow tract obstruction late after repair of congenital heart defects. Circulation113(17), 2037–2044 (2006).
   PubMed Web of Science ®Google Scholar
• Nordmeyer J, Khambadkone S, Coats L et al. Risk stratification, systematic classification, and anticipatory management strategies for stent fracture after percutaneous pulmonary valve implantation. Circulation115(11), 1392–1397 (2007).
   PubMed Web of Science ®Google Scholar
• Boone RH, Webb JG, Horlick E et al. Transcatheter pulmonary valve implantation using the Edwards SAPIEN transcatheter heart valve. Catheter. Cardiovasc. Interv.75(2), 286–294 (2010).
   PubMedGoogle Scholar
• Schievano S, Taylor AM, Capelli C et al. First-in-man implantation of a novel percutaneous valve: a new approach to medical device development. EuroIntervention5(6), 745–750 (2010).
   PubMed Web of Science ®Google Scholar
• O’Laughlin MP. Catheterization treatment of stenosis and hypoplasia of pulmonary arteries. Pediatr. Cardiol.19(1), 48–56; discussion 57–58 (1998).
   PubMedGoogle Scholar
• Marini D, Boudjemline Y, Agnoletti G. Closure of extracardiac Fontan fenestration by using the covered Cheatham Platinum stent. Catheter. Cardiovasc. Interv.69(7), 1002–1006 (2007).
   PubMedGoogle Scholar
• Cowley CG, Badran S, Gaffney D, Rocchini AP, Lloyd TR. Transcatheter closure of fontan fenestrations using the Amplatzer septal occluder: initial experience and follow-up. Catheter. Cardiovasc. Interv.51(3), 301–304 (2000).
   PubMedGoogle Scholar
• Balzer DT, Johnson M, Sharkey AM, Kort H. Transcatheter occlusion of baffle leaks following atrial switch procedures for transposition of the great vessels (d-TGV). Catheter. Cardiovasc. Interv.61(2), 259–263 (2004).
   PubMedGoogle Scholar
• Hill KD, Fudge JC, Rhodes JF. Complete resolution of systemic venous baffle obstruction and baffle leak using the gore excluder(R) covered stent in two patients with transposition of the great arteries and prior mustard procedure. Catheter. Cardiovasc. Interv. DOI: 10.1002/ccd.22567 (2010) (Epub ahead of print).
   Google Scholar
• MacLellan-Tobert SG, Cetta F, Hagler DJ. Use of intravascular stents for superior vena caval obstruction after the Mustard operation. Mayo Clin. Proc.71(11), 1071–1076 (1996).
   PubMedGoogle Scholar
• Chintala K, Forbes TJ, Karpawich PP. Effectiveness of transvenous pacemaker leads placed through intravascular stents in patients with congenital heart disease. Am. J. Cardiol.95(3), 424–427 (2005).
   PubMed Web of Science ®Google Scholar
• Ruiz CE, Feldman TE, Hijazi ZM et al. Interventional fellowship in structural and congenital heart disease for adults. Catheter. Cardiovasc. Interv.76(4), E90–E105 (2010).
   Google Scholar
• Feldman T, Ruiz CE, Hijazi ZM. The SCAI Structural Heart Disease Council: toward addressing training, credentialing, and guidelines for structural heart disease intervention. Catheter. Cardiovasc. Interv.76(4), E87–E89 (2010).
   Google Scholar